Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("OJETTI, V")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 19 of 19

  • Page / 1
Export

Selection :

  • and

Helicobacter pylori infection affects eosinophilic cationic protein in the gastric juice of patients with idiopathic chronic urticariaOJETTI, V; ARMUZZI, A; SCHIAVINO, D et al.International archives of allergy and immunology. 2001, Vol 125, Num 1, pp 66-72, issn 1018-2438Article

Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticariaDI CAMPLI, C; GASBARRINI, A; NUCERA, E et al.Digestive diseases and sciences. 1998, Vol 43, Num 6, pp 1226-1229, issn 0163-2116Article

Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy : A pilot studyARMUZZI, A; CREMONINI, F; GASBARRINI, G et al.Digestion. 2001, Vol 63, Num 1, pp 1-7, issn 0012-2823Article

Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infectionCAMMAROTA, G; CANNIZZARO, O; OJETTI, V et al.Alimentary pharmacology & therapeutics. 2000, Vol 14, Num 1, pp 73-77, issn 0269-2813Article

Helicobacter pylori eradication ameliorates primary Raynaud's phenomenonGASBARRINI, A; MASSARI, I; GASBARRINI, G et al.Digestive diseases and sciences. 1998, Vol 43, Num 8, pp 1641-1645, issn 0163-2116Conference Paper

Moxifloxacin-based strategies for first-line treatment of helicobacter pylori infectionNISTA, E. C; CANDELLI, M; GASBARRINI, G et al.Alimentary pharmacology & therapeutics. 2005, Vol 21, Num 10, pp 1241-1247, issn 0269-2813, 7 p.Article

Beta-lactamase inhibitor enhances Helicobacter pylori eradication rateOJETTI, V; MIGNECO, A; ZOCCO, M. A et al.Journal of internal medicine. 2004, Vol 255, Num 1, pp 125-129, issn 0954-6820, 5 p.Article

Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradicationDI CARO, S; OJETTI, V; ZOCCO, M. A et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 3, pp 527-532, issn 0269-2813Article

Antibodies to Saccharomyces cerevisiae: Are they useful in clinical practice?CANDELLI, M; PAPA, A; NISTA, E. C et al.Hepato-gastroenterology. 2003, Vol 50, Num 51, pp 718-720, issn 0172-6390, 3 p.Article

Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trialNISTA, E. C; CANDELLI, M; CAMMAROTA, G et al.Alimentary pharmacology & therapeutics. 2003, Vol 18, Num 6, pp 627-633, issn 0269-2813, 7 p.Article

Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosaDANESE, S; CREMONINI, F; GASBARRINI, G et al.Scandinavian journal of gastroenterology. 2001, Vol 36, Num 3, pp 247-250, issn 0036-5521Article

Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitusGASBARRINI, A; OJETTI, V; PITOCCO, D et al.Scandinavian journal of gastroenterology. 2000, Vol 35, Num 3, pp 260-263, issn 0036-5521Article

Insulin-dependent diabetes mellitus affects eradication rate of Helicobacter pylori infectionGASBARRINI, A; OJETTI, V; POLA, P et al.European journal of gastroenterology & hepatology. 1999, Vol 11, Num 7, pp 713-716, issn 0954-691XArticle

Extradigestive manifestations of Helicobacter pylori gastric infectionGASBARRINI, A; FRANCESCHI, F; ARMUZZI, A et al.Gut. 1999, Vol 45, pp I9-I12, issn 0017-5749, SUP1Conference Paper

Helicobacter pylori infection in patients affected by insulin-dependent diabetes mellitusGASBARRINI, A; OJETTI, V; PITOCCO, D et al.European journal of gastroenterology & hepatology. 1998, Vol 10, Num 6, pp 469-472, issn 0954-691XArticle

Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitisZOCCO, M. A; DAL VERME, L. Zileri; ARMUZZI, A et al.Alimentary pharmacology & therapeutics. 2006, Vol 23, Num 11, pp 1567-1574, issn 0269-2813, 8 p.Article

The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapyARMUZZI, A; CREMONINI, F; GASBARRINI, G et al.Alimentary pharmacology & therapeutics. 2001, Vol 15, Num 2, pp 163-169, issn 0269-2813Article

Efficacy of a multistep strategy for Helicobacter pylori eradicationGASBARRINI, A; OJETTI, V; FADDA, G et al.Alimentary pharmacology & therapeutics. 2000, Vol 14, Num 1, pp 79-83, issn 0269-2813Article

Beneficial effects of Helicobacter pylori eradication on migraineGASBARRINI, A; DE LUCA, A; FIORE, G et al.Hepato-gastroenterology. 1998, Vol 45, Num 21, pp 765-770, issn 0172-6390Article

  • Page / 1